Shopping Cart
- Remove All
- Your shopping cart is currently empty
PROTAC AR/AR-V7 degrader-1 (27c) serves as a dual degrader targeting both AR and AR-V7, showcasing DC50 values of 2.67 and 2.64 μM for AR and AR-V7, respectively. It effectively induces apoptosis (Red: AR antagonist; Blue: E3 ligase ligand; Black: linker) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | PROTAC AR/AR-V7 degrader-1 (27c) serves as a dual degrader targeting both AR and AR-V7, showcasing DC50 values of 2.67 and 2.64 μM for AR and AR-V7, respectively. It effectively induces apoptosis (Red: AR antagonist; Blue: E3 ligase ligand; Black: linker) [1]. |
In vitro | PROTAC AR/AR-V7 degrader-1 (27c) effectively inhibits the transcriptional activity of the AR signaling pathway. Its IC50 in 22RV1 cells is 0.9 μM [1]. Additionally, PROTAC AR/AR-V7 degrader-1 (27c) overcomes resistance in advanced prostate cancer expressing AR splice variants [1]. |
Molecular Weight | 485.43 |
Formula | C24H19F4N5O2 |
Cas No. | 2841308-96-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.